RoboPharma

Decentralized and agile pharmaceutical production using advanced high-precision robotic dosing technologies.

RoboPharma, led by CurifyLabs (Finland), is a €5.6 million EU-funded initiative developing an AI- and robotics-driven decentralized pharmaceutical manufacturing platform. Funded through the EU4Health programme, the project strengthens Europe’s healthcare resilience by enabling hospitals and pharmacies to locally produce essential and personalized medicines. Together with partners across Europe — Delpech Pharmacy, AtrimusRx, Vaasa Hietalahti Pharmacy, Tartu University Hospital, Fysioline, and University Medical Center Mainz — RoboPharma is shaping a more flexible, patient-centric, and crisis-ready pharmaceutical future.

What is RoboPharma?

CurifyLabs Leads €5.6M EU-Funded RoboPharma Project to Transform On-Demand Pharmaceutical Manufacturing Across Europe.

CurifyLabs is proud to announce the launch of RoboPharma, a groundbreaking €5.6 million EU-funded initiative aiming to create an AI and robotic-driven, decentralised pharmaceutical EU manufacturing platform to enhance crisis preparedness across Europe by enabling high-precision production of essential medicines at the point of care.

The project is funded through the EU4Health programme, with a €3.4 million contribution from the European Union, and addresses one of the most pressing challenges in European healthcare: the fragility and inflexibility of centralized pharmaceutical supply chains during crises such as pandemics, natural disasters, and global disruptions.

RoboPharma’s mission is to develop and deploy a scalable, compliant, and intelligent pharmaceutical production platform specifically designed for hospital and community pharmacies. The system enables local production of personalized and high-demand medicines with unmatched speed, safety, and precision by leveraging robotic dosing technologies, AI-powered workflow automation, advanced connectivity, and real-time quality control.

“RoboPharma is not just a technological leap; it’s a strategic investment in Europe’s healthcare resilience. By empowering local pharmacies and hospitals with advanced production capabilities, we reduce bottlenecks, increase preparedness, and ensure uninterrupted access to critical medicines in shortage and crisis situations.” says Charlotta Topelius, CEO of CurifyLabs.

The RoboPharma consortium is led by CurifyLabs (Finland) and includes six forward-thinking partners across Europe:

Delpech Pharmacy – France
AtrimusRx – Sweden
Vaasa Hietalahti Pharmacy – Finland
Tartu University Hospital – Estonia
Fysioline – Finland
University Medical Center Mainz – Germany

Together, the partners will build, test, and validate the platform in real-world pharmacy and hospital settings, demonstrating its value in everyday operations and crisis scenarios alike.

By bringing production closer to the patient, RoboPharma improves crisis preparedness, brings solutions to address supply during drug shortages, and enhances the flexibility of pharmaceutical production in the EU. The result: readiness to utilize a more resilient, decentralized, and patient-centric pharmaceutical production approach for Europe.

WPs and Objectives

The project is divided into different WPs which are aimed at:

Developing further dispensing technology platform and integrated quality control tools
Developing new inks/excipient bases and quality dossiers based on identified needs
Ensuring effective remote manufacturing and supply chain management
Building partner network for manufacturing inks and ensuring quality control
Expanding platform to include new integrations and functionalities
Piloting and validating developed technologies and processes
Ensuring effective project management and dissemination, exploitation, and communication of project progress and results

Events

Here are upcoming events related to the RoboPharma Project.

Webinar

Our upcoming webinars have not been arranged yet.

Publications and results

Follow the publications and results related to the RoboPharma Project.

Project Leaflet

Take a look at the project leaflet.

Timeline Overview

The RoboPharma project is planned to extend until June 2028.

The main milestones are the following:

6/2025: Project launch
12/2025: Publication of the project's leaflet
12/2026: Dissemination of interim results
12/2026: Workshops regarding the interim results
6/2028: Promotion of the final results
6/2028: Scientific publications

Project Coordinator Contact:

Niklas Sandler

CurifyLabs

Founder & CTO

niklas.sandler@curifylabs.com

+358 503 622 123

Follow the advancement of the project on CurifyLabs' LinkedIn.

Co-funded by the European Union. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA: Neither the European Union nor the granting authority can be held responsible for them.